UBS’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6K Buy
300
+200
+200% +$3.67K ﹤0.01% 9276
2014
Q2
$2K Sell
100
-10,600
-99% -$146K ﹤0.01% 10021
2014
Q1
$152K Buy
+10,700
New +$145K ﹤0.01% 5504
2013
Q4
Sell
-2,300
Closed -$27K 10499
2013
Q3
$27K Buy
2,300
+1,300
+130% +$16.7K ﹤0.01% 7671
2013
Q2
$14K Buy
+1,000
New +$10.9K ﹤0.01% 8267

Other funds holding EXAS

UBS's EXAS Position: Q3 2014 in Review

UBS reduced its Exact Sciences (EXAS) stake by 4.8% in Q3 2014, selling an estimated $130K and leaving 139,795 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2620.

UBS first reported a position in EXAS in Q2 2013 and has held it in 6 quarters since. 175 funds tracked by Wall St. Rank hold EXAS as of Q3 2014.

  • UBS held 139,795 shares of Exact Sciences worth $2.71M as of Q3 2014.
  • UBS sold 7,087 Exact Sciences shares in Q3 2014, an estimated $130K.
  • Exact Sciences made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2620 holding.
  • UBS first reported a position in Exact Sciences in Q2 2013 and has held it in 6 quarters since.
  • 175 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.